C6 Ceramide (d18:1/6:0) as a Novel Treatment of Cutaneous T Cell Lymphoma

SIMPLE SUMMARY: There is no curative treatment for mycosis fungoides and Sézary syndrome, which are the most frequent forms of cutaneous T cell lymphoma (CTCL). Short-chain ceramides like C6 Ceramide are known to induce cell death by both apoptosis and necrosis. Here, we demonstrate that C6 Ceramide...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:Cancers (Basel)
Autors principals: Wilhelm, Raphael, Eckes, Timon, Imre, Gergely, Kippenberger, Stefan, Meissner, Markus, Thomas, Dominique, Trautmann, Sandra, Merlio, Jean-Philippe, Chevret, Edith, Kaufmann, Roland, Pfeilschifter, Josef, Koch, Alexander, Jäger, Manuel
Format: Artigo
Idioma:Inglês
Publicat: MDPI 2021
Matèries:
Article
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC7828274/
https://ncbi.nlm.nih.gov/pubmed/33450826
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3390/cancers13020270
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars